Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug:18:125-31.
doi: 10.1016/j.meegid.2013.03.050. Epub 2013 Apr 11.

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys

Affiliations

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys

Emmi Andersson et al. Infect Genet Evol. 2013 Aug.

Abstract

Identification of recent HIV infection within populations is a public health priority for accurate estimation of HIV incidence rates and transmitted drug resistance at population level. Determining HIV incidence rates by prospective follow-up of HIV-uninfected individuals is challenging and serological assays have important limitations. HIV diversity within an infected host increases with duration of infection. We explore a simple bioinformatics approach to assess viral diversity by determining the percentage of ambiguous base calls in sequences derived from standard genotyping of HIV-1 protease and reverse transcriptase. Sequences from 691 recently infected (≤1 year) and chronically infected (>1 year) individuals from Sweden, Vietnam and Ethiopia were analyzed for ambiguity. A significant difference (p<0.0001) in the proportion of ambiguous bases was observed between sequences from individuals with recent and chronic infection in both HIV-1 subtype B and non-B infection, consistent with previous studies. In our analysis, a cutoff of <0.47% ambiguous base calls identified recent infection with a sensitivity and specificity of 88.8% and 74.6% respectively. 1,728 protease and reverse transcriptase sequences from 36 surveys of transmitted HIV drug resistance performed following World Health Organization guidance were analyzed for ambiguity. The 0.47% ambiguity cutoff was applied and survey sequences were classified as likely derived from recently or chronically infected individuals. 71% of patients were classified as likely to have been infected within one year of genotyping but results varied considerably amongst surveys. This bioinformatics approach may provide supporting population-level information to identify recent infection but its application is limited by infection with more than one viral variant, decreasing viral diversity in advanced disease and technical aspects of population based sequencing. Standardization of sequencing techniques and base calling and the addition of other parameters such as CD4 cell count may address some of the technical limitations and increase the usefulness of the approach.

Keywords: Ambiguity; Bioinformatics; HIV; Incidence; Resistance; Viral diversity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ambiguity analysis of reference sequences from recent and chronic infection. All sequences from recent infections were abstracted from Swedish InfCareHIV. Sequences from individuals with chronic infection were abstracted from Swedish InfCareHIV and from research cohorts in Vietnam and Ethiopia. The ends of the whiskers mark the 5th and 95th percentile. Outliers are marked by dots.
Figure 2
Figure 2
Ambiguity analysis results from surveys of transmitted HIV drug resistance conducted according to WHO guidance. Each survey is numbered from 1 to 36 and presented by WHO subregion. The ends of the whiskers mark the 5th and 95th percentile. Outliers are omitted for clarity. The cutoff for recent infection (<0.47%) is depicted by the dotted line.

References

    1. Abrahams M, Anderson J, Giorgi E, Seoighe C, Mlisana K, Ping L, Athreya G, Treurnicht F, Keele B, Wood N, Salazar-Gonzalez J, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen M, Karim S, Haynes B, Shaw G, Hahn B, Korber B, Swanstrom R, Williamson C C.A.I.S.T.C.f.H.-A.V.I Consortium. Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants. J Virol. 2009;83:3556–3567. - PMC - PubMed
    1. Alcantara L, Cassol S, Libin P, Deforche K, Pybus O, Van Ranst M, Galvao-Castro B, Vandamme A-M, de Oliveira T. A Standardized Framework for Accurate, High-throughput Genotyping of Recombinant and Non-recombinant Viral Sequences. Nucleic Acids Res. 2009:W634–642. - PMC - PubMed
    1. Bennett D, Bertagnolio S, Sutherland D, Gilks C. The World Health organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008a;13(Suppl 2):1–13. - PubMed
    1. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724. - PMC - PubMed
    1. Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008b;13(Suppl 2):25–36. - PubMed

Publication types